Section Arrow
TMDX.NASDAQ
- TransMedics Group
Quotes are at least 15-min delayed:2026/03/09 15:27 EDT
Regular Hours
Last
 133
+3.39 (+2.62%)
Day High 
133 
Prev. Close
129.61 
1-M High
151 
Volume 
702.70K 
Bid
132.84
Ask
133
Day Low
122.38 
Open
125.26 
1-M Low
127.5 
Market Cap 
4.43B 
Currency 美元 
P/E 51.02 
%Yield -- 
10-SMA 139.65 
20-SMA 136.76 
50-SMA 135.04 
52-W High 156 
52-W Low 62.23 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
4.87/3.35
Enterprise Value
4.94B
Balance Sheet
Book Value Per Share
13.79
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
605.49M
Operating Revenue Per Share
5.61
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ABTAbbott Laboratories112.29+2.73+2.49%29.21PE
MDTMedtronic plc91.36+0.46+0.51%25.39PE
BSXBoston Scientific Corp72.195+0.845+1.18%36.78PE
BFLYButterfly Network3.775+0.125+3.42%-- 
PACBPacific Biosciences of California1.375-0.005-0.36%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The companyhas developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.